Patents by Inventor Alan Cherrington

Alan Cherrington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS, DEVICES, COMPOSITIONS, AND METHODS FOR TREATING DIABETES
    Publication number: 20230293639
    Abstract: Systems, devices, compositions, and methods for treating diabetes are provided, including co-administering insulin and glucagon to a patient. Data collected from studies conducted to observe co-administration of insulin and glucagon to a patient are also provided. Optimal ratios of insulin and glucagon administration, as well as target doses for each, are also provided.
    Type: Application
    Filed: June 11, 2021
    Publication date: September 21, 2023
    Inventors: David Maggs, Alan Cherrington, Soumitra S. Ghosh, Christopher A. Rhodes, Jui-Chen Lin, R. Maxwell Flaherty, J. Christopher Flaherty
  • SYSTEMS, COMPOSITIONS AND METHODS FOR TREATING DIABETES
    Publication number: 20220273771
    Abstract: This disclosure provides methods for treatment comprising co-administering insulin and glucagon to a subject, and co-formulations comprising insulin and glucagon.
    Type: Application
    Filed: March 17, 2022
    Publication date: September 1, 2022
    Inventors: Alan Cherrington, David Maggs, Soumitra Ghosh, Christopher A. Rhodes, Jui-Chen Lin
  • Systems, compositions and methods for treating diabetes
    Patent number: 11357829
    Abstract: This disclosure provides methods for treatment comprising co-administering insulin and glucagon to a subject, and co-formulations comprising insulin and glucagon.
    Type: Grant
    Filed: February 2, 2018
    Date of Patent: June 14, 2022
    Assignee: Vanderbilt University
    Inventors: Alan Cherrington, David Maggs, Soumitra Ghosh, Christopher A. Rhodes, Jui-Chen Lin
  • METHOD AND USE OF CONTROLLING POSTPRANDIAL GLUCOSE LEVELS IN A SUBJECT
    Publication number: 20210220443
    Abstract: Disclosed is a method of controlling postprandial blood glucose levels in a subject. The method includes orally administering to a subject an orally administrable oligoethylene glycol conjugate of insulin or an orally administrable insulin fusion protein. Oral administration is done during a time period from about 5 to 25 minutes prior to a meal.
    Type: Application
    Filed: June 17, 2019
    Publication date: July 22, 2021
    Inventors: SANDEEP N. ATHALYE, ANAND KHEDKAR, ALEXAMDER FLEMING, ALAN CHERRINGTON, ASHWINI VISHWESWARAMURTHY, HAROLD E. LEBOVITZ
  • SYSTEMS, COMPOSITIONS AND METHODS FOR TREATING DIABETES
    Publication number: 20200230211
    Abstract: This disclosure provides methods for treatment comprising co-administering insulin and glucagon to a subject, and co-formulations comprising insulin and glucagon.
    Type: Application
    Filed: February 2, 2018
    Publication date: July 23, 2020
    Inventors: Alan Cherrington, David Maggs, Soumitra Ghosh, Christopher A. Rhodes, Jui-Chen Lin